M, V. (2025) “Targeting Metabolic Pathways for Neurodegeneration: The Emerging Role of Anti-Diabetic and Lipid-Lowering Agents”, International Journal of Allied Medical Sciences and Clinical Research, 13(4), pp. 633–642. doi: 10.61096/ijamscr.v13.iss4.2025.633-642.